Ionis Pharmaceuticals, Inc.
IONS
$55.39
-$0.63-1.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -192.79% | 37.03% | -119.83% | 8.45% | 286.45% |
| Total Depreciation and Amortization | 40.04% | 37.98% | 39.38% | -18.04% | -2.24% |
| Total Amortization of Deferred Charges | 9.42% | 43.06% | 17.56% | -1.55% | -1.50% |
| Total Other Non-Cash Items | 21.07% | -33.87% | 37.20% | -113.34% | 48.28% |
| Change in Net Operating Assets | 2,245.87% | -1,673.22% | 138.86% | 36.01% | 69.71% |
| Cash from Operations | 273.69% | -425.83% | -18.57% | -14.30% | 226.24% |
| Capital Expenditure | -30.68% | -73.04% | 16.49% | 41.81% | -97.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 136.73% | 205.18% | -524.94% | 129.12% | -256.90% |
| Cash from Investing | 119.57% | 214.93% | -714.99% | 126.80% | -292.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1,081,280.00% | -4.76% | -500.95% | 14.58% | -2.56% |
| Issuance of Common Stock | 1,474.05% | 2,456.98% | 25,032.17% | -83.62% | -50.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -33,162.87% | 2,503.82% | 1,440.05% | -83.63% | -51.23% |
| Foreign Exchange rate Adjustments | -108.40% | -159.48% | 91.15% | -123.43% | 2,686.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 433.60% | -999.29% | 136.66% | 1.05% | 160.32% |